<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">100883645</journal-id><journal-id journal-id-type="pubmed-jr-id">22008</journal-id><journal-id journal-id-type="nlm-ta">Diabetes Obes Metab</journal-id><journal-id journal-id-type="iso-abbrev">Diabetes Obes Metab</journal-id><journal-title-group><journal-title>Diabetes, obesity &#x00026; metabolism</journal-title></journal-title-group><issn pub-type="ppub">1462-8902</issn><issn pub-type="epub">1463-1326</issn></journal-meta><article-meta><article-id pub-id-type="pmid">38433703</article-id><article-id pub-id-type="pmc">11078605</article-id><article-id pub-id-type="doi">10.1111/dom.15522</article-id><article-id pub-id-type="manuscript">NIHMS1971977</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Accelerated onset of diabetes in NOD mice fed a refined high-fat diet</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Batdorf</surname><given-names>Heidi M.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>de Luna Lawes</surname><given-names>Luz</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="FN1" ref-type="author-notes">&#x001c2;</xref></contrib><contrib contrib-type="author"><name><surname>Cassagne</surname><given-names>Gabrielle A.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Fontenot</surname><given-names>Molly S.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Harvey</surname><given-names>Innocence C.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Richardson</surname><given-names>Jeremy T.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="FN1" ref-type="author-notes">&#x001c2;</xref></contrib><contrib contrib-type="author"><name><surname>Burk</surname><given-names>David H.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Dupuy</surname><given-names>Samuel D.</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Karlstad</surname><given-names>Michael D.</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Salbaum</surname><given-names>J. Michael</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Staszkiewicz</surname><given-names>Jaroslaw</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Beyl</surname><given-names>Robbie</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Ghosh</surname><given-names>Sujoy</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Burke</surname><given-names>Susan J.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Collier</surname><given-names>J. Jason</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Pennington Biomedical Research Center, Baton Rouge, LA 70808</aff><aff id="A2"><label>2</label>Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803</aff><aff id="A3"><label>3</label>Department of Surgery, University of Tennessee Health Science Center, Graduate School of Medicine, Knoxville, TN 37920</aff><author-notes><fn fn-type="present-address" id="FN1"><label>&#x001c2;</label><p id="P1">present address: Louisiana State University School of Medicine, New Orleans 70112.</p></fn><fn fn-type="con" id="FN2"><p id="P2">Author contributions</p><p id="P3">Conceptualization: S.J.B. and J.J.C.; Data curation: H.M.B., S.J.B., S.G., J.S., J.M.S., M.S.F., and J.J.C.; Funding acquisition: S.J.B. and J.J.C.; Investigation: H.M.B, L.L.L., G.A.C., M.S.F., I.C.H., J.M.R., D.H.B., S.D.D., M.D.K., J.S., S.G., J.M.S., S.J.B. M.S.F.,; Methodology: H.M.B., D.H.B., S.G., J.M.S., R.B.; Project administration: S.J.B and J.J.C.; Writing - original draft: S.J.B. and J.J.C.; Writing - review &#x00026; editing: H.M.B, L.L.L., G.A.C., I.C.H., J.M.R., D.H.B., S.D.D., M.D.K., J.S., S.G., J.M.S., S.J.B and J.J.C.</p></fn><corresp id="CR1"><label>*</label>Corresponding Authors: Susan J. Burke, Ph.D., Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA 70808, <email>susan.burke@pbrc.edu</email>, J. Jason Collier, Ph.D., Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA 70808, <email>Jason.collier@pbrc.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>15</day><month>3</month><year>2024</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>04</day><month>3</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>6</month><year>2025</year></pub-date><volume>26</volume><issue>6</issue><fpage>2158</fpage><lpage>2166</lpage><abstract id="ABS1"><sec id="S1"><title>Objective:</title><p id="P4">Type 1 diabetes results from autoimmune events influenced by environmental variables, including changes in diet. This study investigated how feeding refined versus unrefined (aka &#x02018;chow&#x02019;) diets affects the onset and progression of hyperglycemia in non-obese diabetic (NOD) mice.</p></sec><sec id="S2"><title>Methods:</title><p id="P5">Female NOD mice were fed either unrefined diets or matched refined low- and high-fat diets. The onset of hyperglycemia, glucose tolerance, food intake, energy expenditure, circulating insulin, liver gene expression, and microbiome changes were measured for each dietary group.</p></sec><sec id="S3"><title>Results:</title><p id="P6">NOD mice consuming unrefined (chow) diets developed hyperglycemia at similar frequencies. By contrast, mice consuming the defined high-fat diet had an accelerated onset of hyperglycemia compared to the matched low-fat diet. There was no change in food intake, energy expenditure, or physical activity within each respective dietary group. Microbiome changes were driven by diet type, with chow diets clustering similarly while refined low- and high-fat bacterial diversity also grouped closely. In the defined dietary cohort, liver gene expression changes in high-fat-fed mice were consistent with a greater frequency of hyperglycemia and impaired glucose tolerance.</p></sec><sec id="S4"><title>Conclusion:</title><p id="P7">Glucose intolerance is associated with enhanced frequency of hyperglycemia in female NOD mice fed a defined high-fat diet. Using an appropriate matched control diet is an essential experimental variable when studying changes in microbiome composition and diet as a modifier of disease risk.</p></sec></abstract><kwd-group><kwd>autoimmunity</kwd><kwd>diabetes</kwd><kwd>diet</kwd><kwd>non-obese diabetic (NOD) mouse model</kwd><kwd>microbiome</kwd><kwd>obesity</kwd></kwd-group></article-meta></front><body><sec id="S5"><label>1.</label><title>Introduction</title><p id="P8">Type 1 diabetes (T1D) is an autoimmune disease associated with immune cell infiltration into pancreatic tissue, targeting of pancreatic islet &#x003b2;-cells, and subsequent reductions in circulating insulin <sup><xref rid="R1" ref-type="bibr">1</xref>&#x02013;<xref rid="R3" ref-type="bibr">3</xref></sup>. There are multiple proposed risk factors for T1D, including genetic components, such as the inheritance of specific MHC and HLA alleles <sup><xref rid="R4" ref-type="bibr">4</xref></sup>. Indeed, the MHC and HLA alleles in mice and humans show similar sequence specificity <sup><xref rid="R5" ref-type="bibr">5</xref></sup>. In addition, other putative environmental modifiers of disease risk, coupled with genetic susceptibility, are proposed to increase the likelihood of developing T1D. For example, viral exposure <sup><xref rid="R6" ref-type="bibr">6</xref></sup>, lack of sunlight <sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref></sup>, hygiene <sup><xref rid="R9" ref-type="bibr">9</xref></sup>, and diet <sup><xref rid="R10" ref-type="bibr">10</xref></sup> have all been considered disease-modifying risk factors.</p><p id="P9">Diet is critical because greater access to calorically dense foods and a sedentary lifestyle in modern society promotes obesity which is associated with insulin resistance and increased risk for diabetes <sup><xref rid="R11" ref-type="bibr">11</xref></sup>. Individuals with genetic risk for T1D are subject to the same lifestyle and environmental factors as those with the propensity to develop T2D (Type 2 diabetes). Indeed, insulin resistance has been proposed as a possible explanation for the rise in T1D <sup><xref rid="R12" ref-type="bibr">12</xref></sup>. However, appropriate modeling of dietary factors in pre-clinical models has been hampered by inappropriate or suboptimal experimental designs, concerns which have been reviewed previously <sup><xref rid="R13" ref-type="bibr">13</xref>&#x02013;<xref rid="R16" ref-type="bibr">16</xref></sup>.</p><p id="P10">One additional factor proposed to contribute to T1D, and potentially influenced by diet, is alterations to the gut microbiome. Indeed, studies have been conducted to examine the relationship between microbiome changes and diabetes onset <sup><xref rid="R17" ref-type="bibr">17</xref></sup>. For example, germ free mice develop diabetes at the same rate as mice housed in specific pathogen free conditions <sup><xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R19" ref-type="bibr">19</xref></sup>. However, the presence or absence of gut microorganisms undoubtedly influence diabetes within specific genetic contexts <sup><xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref></sup>. Thus, whether changes in glycemia alter the gut microbe composition or changes in bacterial diversity in the host digestive system influence hyperglycemia are not fully resolved.</p><p id="P11">In the present study, we demonstrate that comparison of appropriate control diets is critical for interpreting hyperglycemia onset in NOD mice consuming a high-fat diet. When comparing NOD mice consuming refined matched low- and high-fat diets, there is a greater incidence of hyperglycemia in mice consuming the high-fat diet. When mice consume an unrefined (aka &#x02018;chow&#x02019;) diet, doubling the fat content of the chow diet did not influence the onset of hyperglycemia. These changes also appear to be mirrored in microbiome composition and diversity which were significantly impacted by the type of diet (unrefined versus refined) but differed less when compared within each respective matched dietary group.</p></sec><sec id="S6"><label>2.</label><title>Methods</title><sec id="S7"><label>2.1</label><title>Animals and body composition measurements.</title><sec id="S8"><label>2.1.1</label><title>Unrefined Diet (aka chow) Studies</title><p id="P12">Fifty-six NOD/ShiLtJ (Stock # 001976) female mice were purchased from the Jackson Laboratory (Bar Harbor, ME) at 6 weeks of age. Mice were allowed to acclimate to a 12 hr light-dark cycle at 24&#x000b0;C in the animal facility for a minimum of one week prior to experimental procedures. All mice were given Lab Diet 5001 upon arrival at the facility. Forty of the mice were randomized into groups of twenty mice receiving either Lab Diet 5001 (13% kcal from fat; Lab Diet, St. Louis, MO) or Lab Diet 5015 (26% kcal from fat; Lab Diet, St. Louis, MO) with twenty mice beginning on Lab Diet 5015 at 8 weeks of age. Randomization was conducted using baseline body mass to confirm that all groups began with body mass values that were not statistically different. The animals monitored for diabetes onset were multi-housed and had <italic toggle="yes">ad libitum</italic> access to water and food. Body mass and body composition measurements (fat, lean mass, and fluid mass) were started at 8 or 10 weeks of age and then every two weeks until onset of hyperglycemia using a Bruker Minispec LF110 Time-Domain NMR system. Blood glucose was measured from tail blood using a Bayer Contour Glucometer at baseline (start of study) and twice per week thereafter. Animals were euthanized at onset of hyperglycemia (2 consecutive daily measurements &#x02265;250 mg/dL) or by 20 weeks of age. Frequency of diabetes in female NOD mice in our facility is 75% by 30 weeks of age. Animals were fasted for 4 h followed by CO<sub>2</sub> asphyxiation and cervical dislocation. Pancreata were fixed in 10% (volume/volume) neutral buffered formalin for histological analysis. Trunk blood was collected and the serum fraction was separated for downstream analysis. The additional sixteen mice were randomized using the same strategy and used for metabolic cage studies as described below.</p></sec><sec id="S9"><label>2.1.2</label><title>Refined Diet Studies</title><p id="P13">A separate cohort of fifty-six NOD/ShiLtJ (Stock # 001976) female mice were purchased from the Jackson Laboratory (Bar Harbor, ME) at 6 weeks of age. Mice were allowed to acclimate to a 12 hr light-dark cycle at 24&#x000b0;C in the animal facility for a minimum of one week prior to experimental procedures. For studies monitoring hyperglycemia, the animals were multi-housed and had <italic toggle="yes">ad libitum</italic> access to water and 10% kcal purified low-fat diet (LF) (catalog #: D12450H; Research Diets, Inc, New Brunswick, NJ) upon arrival at the facility. Body mass and body composition measurements (fat, lean mass, and fluid mass) were generated starting at 9 weeks of age and then weekly until onset of hyperglycemia using a Bruker Minispec LF110 Time-Domain NMR system. Blood glucose was measured from tail blood using a Bayer Contour Glucometer at baseline (start of study) and after randomization (as described in 2.1.1) and assignment to dietary group, twice per week thereafter. At 8 weeks of age, the mice were given either LF (n=20) or 45% kcal high fat diet (HF) (n=20; catalog#: D12451; Research Diets, Inc, New Brunswick, NJ). Animals were euthanized at onset of hyperglycemia (2 consecutive daily measurements &#x02265;250 mg/dL) or by 30 weeks of age. Animals were fasted for 4 h followed by CO<sub>2</sub> asphyxiation and cervical dislocation. Liver was snap frozen in liquid nitrogen and pancreata were fixed in 10% (volume/volume) neutral buffered formalin for histological analysis. Trunk blood was collected, and the serum fraction was separated for downstream analysis. The additional sixteen mice were randomized using the same strategy and used for metabolic cage studies as described below. All animal procedures were approved by Institutional Animal Care and Use Committees at Pennington Biomedical Research Center and the University of Tennessee.</p></sec></sec><sec id="S10"><label>2.2</label><title>Glucose Tolerance Tests.</title><sec id="S11"><title>Unrefined (aka chow) Diet and Refined Diet</title><p id="P14">A glucose tolerance test (GTT) was performed in 14 week old female NOD mice following a 4 h fast using intraperitoneal (i.p.) injections of glucose at 2.5g/kg body weight. For both cohorts receiving GTTs, blood glucose was measured from tail blood using the Bayer Contour Glucometer.</p></sec></sec><sec id="S12"><label>2.3</label><title>Metabolic Cage Analyses</title><p id="P15">For metabolic cage measurements, eight mice on each of the four diets as described above were placed at eleven weeks of age into training cages for one week of acclimation. Thus, they were twelve weeks of age upon entry into the metabolic cage (Promethion Metabolic Screening Cages, Sable Systems International, Las Vegas, NV) for continuous measurements. Corn cob bedding was included and there was an intake manifold (a small metal tube that runs along the perimeter of the cage to pull air). The training cage was exactly the same (bedding, dimensions, etc.) as the testing cage, minus the manifold on the perimeter of the cage. Mice were single housed in the training cages and also in the metabolic cages during measurements.</p></sec><sec id="S13"><label>2.4</label><title>Serum Hormone and Gene Expression Measurements</title><p id="P16">Serum insulin was measured using the Mouse Insulin ELISA kit from Mercodia (Uppsala, Sweden) according to the manufacturer&#x02019;s instructions. RNA was isolated from liver using RNeasy extraction kits (Qiagen) and cDNA synthesis was carried out using iScript (Bio-Rad). Real-time PCR was conducted using SYBR Green (Bio-Rad) run on a CFX Opus instrument (Bio-Rad) with gene specific primers (available upon request). Gene expression was normalized to the Ribosomal Protein S9 (Rs9) gene using the delta-delta Ct method.</p></sec><sec id="S14"><label>2.5</label><title>Stool Microbiome</title><p id="P17">Fresh stool samples were collected from each mouse in all groups, unrefined (13%), unrefined (26%), refined (10%), and refined (45%) fed mice, at 16 weeks of age into a 2.0 mL microcentrifuge tube and placed on ice prior to DNA isolation. DNA was prepared from fecal samples via bead beating and subsequent isolation using the QIAamp DNA Stool Mini Kit (Qiagen). The V4 region of the 16S rRNA gene was amplified via PCR using barcoded primer sequences. Amplicons were sequenced using the Illumina MiSeq platform (250-bp/paired-end reads). To reduce technical confounding from batch effects, all samples were sequenced at the same time and the sequencing order was randomized.</p></sec><sec id="S15"><label>2.6</label><title>Microbiome Data Analysis</title><p id="P18">Amplicons were processed via Mothur v. 1.48.0 using default analysis settings <sup><xref rid="R21" ref-type="bibr">21</xref></sup>. Operational taxonomic units (OTUs) delimited at 97% identity were identified and classified according to SILVA reference files release 132 <sup><xref rid="R22" ref-type="bibr">22</xref></sup>. After application of standard quality control measures, the library size per sample ranged from 14827 to 1077789. A total of 2123 unique OTUs were observed demonstrating high-quality clustering. The mean sequencing error rate was very close to 0% based on parallel sequencing of a mock community. Estimates of alpha and beta diversities (intra- and inter-sample diversities, respectively) were obtained with Marker Data Profiling module of MicrobiomAnalyst 2.0 <sup><xref rid="R23" ref-type="bibr">23</xref></sup>. The alpha diversity was primarily estimated based on the observed OTU richness. Weighted and unweighted UniFrac distances were used to estimate beta diversity. Diversity metrics were calculated based on sequence counts scaled with cumulative sum scaling normalization.</p></sec><sec id="S16"><label>2.7</label><title>Pancreas Immunohistochemistry</title><p id="P19">Embedding, sectioning, and staining of formalin-fixed paraffin-embedded (FFPE) tissues was conducted as described previously <sup><xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R25" ref-type="bibr">25</xref></sup>. Five micron sections of FFPE tissue was cut onto slides for immunofluorescence staining assays and incubated overnight at room temperature with rat anti-Foxp3 (1:100, Invitrogen 14&#x02013;5773-82). After three washes at five minutes each with TBST, slides were incubated with Vector Goat anti-Rat HRP polymer for 30 min then washed with TBST, followed by exposure to Biotium CF488 Tyramide (1 uM) in Biotium Amplification Buffer Plus for 10 minutes. Additional primary antibodies were Rabbit anti-CD3 (1:500; ab16669) used at room temperature for 1.5 hours and Rabbit anti-Iba1 (1:1000; Wako 019&#x02013;19741) and Guinea Pig anti-Insulin (1:500; ab7842) used overnight at four degrees. After counterstain with Hoechst, the slides were mounted in Vectashield Vibrance. Insulitis scoring was conducted as previously described <sup><xref rid="R24" ref-type="bibr">24</xref></sup>. We used the following classification scheme to allow for a semiquantitative analysis: 0 indicates no visible infiltration; 1, visible peri-insulitis with &#x0003c;10% of islet occluded; 2, visible peri-insulitis with partially or complete immune cell encircling the islet but affecting less than half of the islet area; 3, invasive insulitis, defined as comprising 50% or more of the islet area being occluded with leukocytic infiltration. The number of islets quantified for each dietary group are represented as follows: total number of islets/total number of sections analyzed where each section is from an individual mouse. 13% unrefined (73/8), 26% unrefined (102/8), 10% refined (175/13), and 45% refined (182/11).</p></sec><sec id="S17"><label>2.8</label><title>Statistical Analysis.</title><p id="P20">Statistical analysis was performed using GraphPad Prism 10.1.2 (GraphPad Software, La Jolla, CA). Outliers were detected using the ROUT method with the standard settings (Q = 1%). Otherwise, all data were analyzed by two-tailed Student&#x02019;s t-test, one-way analysis of variance (ANOVA) using a Tukey&#x02019;s post hoc, Chi Square analysis (Kaplan-Meier curves), Kruskal-Wallis (microbiome distribution) or repeated-measures ANOVA (for longitudinal measures of body weight and body composition). Data are represented as means &#x000b1; SEM.</p></sec></sec><sec id="S18"><label>3.</label><title>Results</title><sec id="S19"><label>3.1</label><title>High-fat fed NOD mice show a greater incidence of diabetes when compared with matched refined low-fat diet but display no differences in diabetes onset when consuming unrefined (aka chow) diets.</title><p id="P21">Female NOD mice were started on either unrefined (13% or 26% fat kcal) or refined (10% or 45% fat kcal) diets. A glucose tolerance test reveals a trend towards slower clearance of glucose in the unrefined (26%) relative to the unrefined (13%; <xref rid="F1" ref-type="fig">Figure 1A</xref>). When NOD mice are fed refined diets, there is reduced glucose tolerance in the high-fat (45%) relative to the low-fat refined (10%) group (<xref rid="F1" ref-type="fig">Figure 1B</xref>). When all mice were monitored for diabetes onset, those consuming the unrefined diets developed diabetes at similar frequencies (<xref rid="F1" ref-type="fig">Figure 1C</xref>; compare black and red lines; p = 0.20, designated as n.s.). However, mice on refined diets reveal that high-fat feeding accelerated diabetes onset at a greater incidence when compared with matched low-fat controls (<xref rid="F1" ref-type="fig">Figure 1C</xref>; compare green and blue lines; p = 0.07, designated by #). Thus, type of diet (unrefined versus refined) influences the time to hyperglycemia onset in female NOD mice.</p></sec><sec id="S20"><label>3.2</label><title>Respiratory quotient (RQ) is influenced by diet.</title><p id="P22">Body mass was similar between each group on unrefined (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 1A</xref>) and refined diets (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 1B</xref>). Fat mass was also comparable between mice within each respective diet group (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 1C</xref> and <xref rid="SD1" ref-type="supplementary-material">Figure 1D</xref>). There was no difference in lean mass in each dietary group diet (compare <xref rid="SD1" ref-type="supplementary-material">Supplementary Figures 1E</xref> with <xref rid="SD1" ref-type="supplementary-material">1F</xref>).</p><p id="P23">Mice on both unrefined (<xref rid="SD2" ref-type="supplementary-material">Supplementary Figure 2A</xref>) and refined (<xref rid="SD2" ref-type="supplementary-material">Supplementary Figure 2B</xref>) diets displayed similar energy expenditure across one week of measurements. When examining spontaneous physical activity, mice on unrefined diets (<xref rid="SD2" ref-type="supplementary-material">Supplementary Figure 2C</xref>) were not different. In addition, there were no changes in food intake (<xref rid="SD2" ref-type="supplementary-material">Supplementary Figure 2D</xref>) or water intake (<xref rid="SD2" ref-type="supplementary-material">Supplementary Figure 2E</xref>) in mice consuming the unrefined diets. Furthermore, mice fed refined (10% and 45%) also had no differences in physical activity (<xref rid="SD2" ref-type="supplementary-material">Supplementary Figure 2F</xref>), food intake (<xref rid="SD2" ref-type="supplementary-material">Supplementary Figure 2G</xref>), or water intake (<xref rid="SD2" ref-type="supplementary-material">Supplementary Figure 2H</xref>).</p><p id="P24">When fed unrefined diets, mice on the higher fat version (26% kcal) had greater RQ values across the week which cycled by light/dark cycle (<xref rid="F2" ref-type="fig">Figure 2A</xref>). The cumulative RQ was higher in the 26% fat group versus the 13% fat group (<xref rid="F2" ref-type="fig">Figure 2B</xref>), which was consistent with greater RQ in both the light and dark cycles in mice fed these unrefined diets (<xref rid="F2" ref-type="fig">Figure 2C</xref>). Alternatively, RQ was greater in mice given the low-fat (10% kcal) compared with the high-fat (45% kcal) refined diet (<xref rid="F2" ref-type="fig">Figure 2D</xref>). These data were consistent when observed cumulatively (<xref rid="F2" ref-type="fig">Figure 2E</xref>) and when parsed out by light and dark cycles (<xref rid="F2" ref-type="fig">Figure 2F</xref>).</p></sec><sec id="S21"><label>3.3</label><title>High-fat feeding promoted elevated circulating insulin in normoglycemic mice but produced no obvious alterations in immune cell invasion into pancreatic islets.</title><p id="P25">Serum insulin is influenced by fat content in the diet with mice eating the higher fat unrefined diet displaying greater insulin quantities prior to disease onset (<xref rid="F3" ref-type="fig">Figure 3A</xref>; NG, normoglycemic). Once mice became hyperglycemic, serum insulin levels were detectably reduced in mice consuming the unrefined diet with higher fat content (<xref rid="F3" ref-type="fig">Figure 3A</xref>; HG, hyperglycemic). Similar results were obtained with mice consuming the refined low- and high-fat diets (<xref rid="F3" ref-type="fig">Figure 3B</xref>). Within the refined diets, the greater incidence of hyperglycemia occurred in the high fat group (<xref rid="F1" ref-type="fig">Figure 1</xref>); therefore, we next measured immune cell infiltration in and near islets as a possible explanation for these findings. Insulitis scoring revealed similar immune cell infiltration patterns in both low-fat and high-fat fed mice (<xref rid="F3" ref-type="fig">Figure 3C</xref>). Staining for specific immune cell types, such as regulatory T-cells (FoxP3+), T-lymphocytes (CD3+), and macrophages (IBA1+) were also congruent with insulitis scoring patterns for each diet (<xref rid="F3" ref-type="fig">Figure 3D</xref>). We noted that hyperglycemic mice had more severe insulitis scores when compared with normoglycemic mice. Finally, we observed that ICAM-1, a protein involved in cell-cell contacts and immune cell activation <sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup>, did not appear to be altered by high-fat feeding (<xref rid="SD4" ref-type="supplementary-material">Supplementary Figure 3</xref>).</p></sec><sec id="S22"><label>3.4</label><title>High-fat feeding alters liver gene expression patterns in female NOD mice.</title><p id="P26">NOD mice fed the refined high-fat diet show reduced hepatic expression of the <italic toggle="yes">Acaca</italic> and <italic toggle="yes">Fasn</italic> genes and increased expression of <italic toggle="yes">Dgat1</italic> and <italic toggle="yes">Dgat2</italic> (<xref rid="F4" ref-type="fig">Figures 4A</xref>&#x02013;<xref rid="F4" ref-type="fig">D</xref>). This gene expression pattern is consistent with reduced hepatic <italic toggle="yes">de novo</italic> lipogenesis, while maintaining triglyceride storage capability, phenotypes documented in other strains of mice fed matched low- and high-fat diets <sup><xref rid="R27" ref-type="bibr">27</xref></sup>. Moreover, there was increased expression of <italic toggle="yes">Slc2a2</italic> and <italic toggle="yes">Pck1</italic>, which encode GLUT2 and PEPCK, respectively, in NOD mice fed a refined high-fat diet (<xref rid="F4" ref-type="fig">Figures 4E</xref> &#x00026; <xref rid="F4" ref-type="fig">F</xref>). These latter changes in gene expression could support increased hepatic glucose production as one possible mechanism explaining an increased onset of hyperglycemia in mice fed a refined high-fat diet. Consistent with similar onset of diabetes in the unrefined (chow) diets (<xref rid="F1" ref-type="fig">Figure 1</xref>), there were no major gene expression changes between the unrefined diets in the livers of these mice (data not shown).</p></sec><sec id="S23"><label>3.5</label><title>Alpha and beta diversity are highly influenced by unrefined versus refined diets.</title><p id="P27">With no major changes in body mass, body composition, or energy expenditure between the mice on each respective type of diet (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figures 1</xref> and <xref rid="SD2" ref-type="supplementary-material">2</xref>), we next tested the premise that diet influences microbiome changes. After filtering out low expression and low variance operational taxonomic units (OTUs), the remaining OTUs represented 38 unique bacterial genera across five phyla (Actinobacterial, Bacteroidetes, Firmicutes, Tenericutes, and Verrucomicrobia; <xref rid="SD7" ref-type="supplementary-material">Supplementary Figure 4A</xref>). At the genus level, organismal diversity clustered by type of diet (13% unrefined similar to 26% unrefined; 10% refined similar to 45% refined; <xref rid="SD7" ref-type="supplementary-material">Supplementary Figure 4B</xref>).</p><p id="P28">Within the unrefined diet groups, a much higher compositional diversity (alpha diversity, measured by Shannon diversity index) was observed compared to the stool samples from the refined diets (<xref rid="F5" ref-type="fig">Fig. 5A</xref>), resulting in a highly statistically significant difference across the four dietary groups (Kruskall-Willis H=25.3, p-value = 1.31E-05; <xref rid="F5" ref-type="fig">Fig 5A</xref>). This significance was primarily driven by the diversity indices of the unrefined groups compared to the indices for the refined diet groups. The alpha-diversity indices were more similar between unrefined groups (within group comparison) than to refined 10% and 45% fat diets (across group comparison). These results argue for a qualitative difference in the richness of taxa in the unrefined-fed animals compared to the mice fed the refined 10% and 45% fat diets. The beta-diversity index further estimated the differences in microbiota composition across the four groups. As seen in the principal component analysis plot (<xref rid="F5" ref-type="fig">Fig. 5B</xref>), samples belonging to the unrefined groups clustered together, whereas a separate cluster was observed for the refined diet samples. Testing via the PERMANOVA method showed an overall statistically significant difference across the four groups (F=21.2, p-value &#x0003c;0.001). Post-hoc testing showed the greatest pairwise differences between unrefined 13% and refined 45% diet (F=40.03, p&#x0003c;0.001) and unrefined 26% versus refined 10% diet (F=22.1, p&#x0003c;0.001). Comparing defined LF- to HF-diet driven microbiota communities directly, we observed 52 OTUs that were deemed statistically significantly different (<xref rid="SD5" ref-type="supplementary-material">Supplementary Table 1</xref>). Community members with the highest representation in this group include members of the genera Staphylococcus, Clostridium senso stricto, and Turicibacter; all these are significantly reduced in the HF diet-shaped communities. Conversely, members of the phylum proteobacteria &#x02013; belonging to the family Desulfovibrionaceae &#x02013; show increased representation in the HF-shaped community. While Desulfovibrio sp. have been linked to metabolic syndrome inflammation <sup><xref rid="R28" ref-type="bibr">28</xref></sup>, direct links to autoimmunity are unclear at this time. In summary, we conclude that microbiome changes are influenced by type of diet (i.e., unrefined versus refined) but do not necessarily contribute to increased or decreased outcome measures used in this study.</p></sec></sec><sec id="S24"><label>4.</label><title>Discussion</title><p id="P29">The prevalence of both major forms of diabetes, T1D and T2D, has increased over the past two decades <sup><xref rid="R29" ref-type="bibr">29</xref></sup>. While many possibilities may exist to explain these increases in disease prevalence, diet is certainly one likely risk factor. Here, we have used the NOD mouse, the gold standard preclinical model for T1D <sup><xref rid="R30" ref-type="bibr">30</xref></sup>, to test the hypothesis that high-fat feeding alters the course of hyperglycemia onset. We found that feeding a refined high-fat diet increases the prevalence of diabetes in female NOD mice when compared with a matched refined low-fat diet. Therefore, our data does not support previous work showing that high-fat diet prevents autoimmune diabetes in NOD mice <sup><xref rid="R31" ref-type="bibr">31</xref></sup>. We suspect this difference in experimental outcomes is due to the distinct dietary conditions used in each study.</p><p id="P30">High-fat diets have been primarily used in mice not prone to autoimmune disease, focusing on the development of obesity and associated metabolic outcomes, such as impaired glucose tolerance and insulin resistance <sup><xref rid="R32" ref-type="bibr">32</xref></sup>. However, many such studies using high-fat diets have not selected an appropriate control diet in the experimental design, which drastically alters the interpretation of the data <sup><xref rid="R14" ref-type="bibr">14</xref>&#x02013;<xref rid="R16" ref-type="bibr">16</xref></sup>. Herein, we used two different unrefined (aka chow) diets and two distinct, refined matched low- and high-fat diets to investigate their impact on hyperglycemia development in female NOD mice.</p><p id="P31">NOD mice eating the refined high-fat diet developed hyperglycemia more frequently than their counterparts on a matched low-fat diet (<xref rid="F1" ref-type="fig">Figure 1</xref>). We found that NOD mice consuming unrefined &#x02018;chow&#x02019; diets developed diabetes at similar rates but also exhibited hyperglycemia earlier than mice on refined diets (<xref rid="F1" ref-type="fig">Figure 1</xref>). A previous study concluded that high-fat feeding prevents or slows the development of hyperglycemia in female NOD mice, but did so by comparing an unrefined (chow) diet to a refined high-fat diet <sup><xref rid="R31" ref-type="bibr">31</xref></sup>. When comparing the unrefined dietary groups with the refined HF group in the present study (<xref rid="F1" ref-type="fig">Figure 1C</xref> &#x02013; compare black line to blue line), our experiments recapitulate this prior report. However, when mice are fed appropriately matched refined low- and high-fat diets, we found that high-fat diet consumption promotes the development of hyperglycemia (<xref rid="F1" ref-type="fig">Figure 1C</xref> &#x02013; compare green line to blue line). Consequently, the general conclusion that high fat prevents or slows development of hyperglycemia may need revision, because with the correct matched control diet, we observed that a refined high-fat diet advanced the pathological condition. Thus, selection of the most appropriate control diet is a highly essential factor influencing the interpretation of the study results <sup><xref rid="R14" ref-type="bibr">14</xref>&#x02013;<xref rid="R16" ref-type="bibr">16</xref></sup>.</p><p id="P32">We suspect that the impaired glucose tolerance observed in high-fat fed mice (<xref rid="F1" ref-type="fig">Figure 1</xref>) is an early predictor of hyperglycemia in mice as it is in humans <sup><xref rid="R33" ref-type="bibr">33</xref>,<xref rid="R34" ref-type="bibr">34</xref></sup>. It is possible that high-fat feeding imparts greater stress on &#x003b2;-cells, promotes hepatic glucose production, or both leading to impaired glucose tolerance. We note that mice consuming the refined high-fat diet had reduced expression of genes involved with <italic toggle="yes">de novo</italic> lipogenesis (DNL; <xref rid="F4" ref-type="fig">Figures 4A</xref> and <xref rid="F4" ref-type="fig">4B</xref>) concomitant with greater expression of genes controlling triglyceride synthesis in the liver (<xref rid="F4" ref-type="fig">Figures 4C</xref> and <xref rid="F4" ref-type="fig">4D</xref>). These gene expression results in NOD mice are consistent with the suppression of DNL in the BDF1 mouse model fed a high-fat diet <sup><xref rid="R27" ref-type="bibr">27</xref></sup> and in humans <sup><xref rid="R35" ref-type="bibr">35</xref></sup>. In addition, we found that refined high-fat fed mice had increased expression of the genes encoding phosphoenolpyruvate carboxykinase (<italic toggle="yes">Pck1</italic> encoding PEPCK) and (<italic toggle="yes">Slc2a2</italic> encoding GLUT2) in the liver (<xref rid="F4" ref-type="fig">Figures 4E</xref> and <xref rid="F4" ref-type="fig">4F</xref>). Fatty acids increase expression of PEPCK in culture and enhanced hepatic PEPCK expression leads to glucose intolerance <italic toggle="yes">in vivo</italic>
<sup><xref rid="R36" ref-type="bibr">36</xref>&#x02013;<xref rid="R38" ref-type="bibr">38</xref></sup>. Collectively, these findings are congruent with refined high-fat feeding altering liver metabolism in a manner consistent with the acceleration of hyperglycemia in NOD mice (<xref rid="F1" ref-type="fig">Figure 1</xref>). Finally, we also note the larger amount of sucrose in the refined diets (<xref rid="F2" ref-type="fig">Figures 2D</xref>&#x02013;<xref rid="F2" ref-type="fig">F</xref>) was likely to be a major factor influencing RQ values. Sucrose is low to absent from traditional unrefined diets, including those used in the present study (<xref rid="F2" ref-type="fig">Figures 2A</xref>&#x02013;<xref rid="F2" ref-type="fig">C</xref>). Sucrose and other carbohydrate sources are known to influence the RQ value <sup><xref rid="R39" ref-type="bibr">39</xref>&#x02013;<xref rid="R41" ref-type="bibr">41</xref></sup>.</p><p id="P33">Our preclinical data showing changes in glucose tolerance preceding hyperglycemia are compatible with alterations in glucose tolerance predicting the likelihood of T1D onset in humans <sup><xref rid="R42" ref-type="bibr">42</xref></sup>. Additionally, a high-fat diet could promote chronic low-grade inflammation that exacerbates the disease factors associated with autoimmunity. For example, inflammatory stimuli enhance MHC II complexes on antigen-presenting cells <sup><xref rid="R43" ref-type="bibr">43</xref></sup>, which in T1D may promote greater disease risk. Furthermore, glucose intolerance, insulin resistance, and obesity intensify or accelerate the onset of many diseases and also make treating such conditions more difficult <sup><xref rid="R44" ref-type="bibr">44</xref>&#x02013;<xref rid="R46" ref-type="bibr">46</xref></sup>.</p><p id="P34">Another potential factor contributing to autoimmunity is the microbiome. Indeed, many studies report investigating the relationship between microbiome changes and diabetes onset <sup><xref rid="R17" ref-type="bibr">17</xref></sup>. For example, germ free mice develop diabetes at the same rate as mice housed in specific pathogen free conditions <sup><xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R19" ref-type="bibr">19</xref></sup>. However, the presence or absence of gut microorganisms undoubtedly influence diabetes within specific genetic contexts <sup><xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref></sup>. When assessing alterations in the microbiome, it appears that phylogenetic diversity fluctuates with type of diet (e.g., unrefined versus refined), but may be modulated less drastically within matched dietary groups. Thus, microbiome changes are a readout of changes in food composition (i.e., unrefined to refined; ref. <sup><xref rid="R13" ref-type="bibr">13</xref></sup> and present data). However, whether such alterations are directly associated with the onset or progression of autoimmune disease and to what extent microbiome changes modify disease risk is not entirely understood. Nevertheless, a consistent viewpoint is that comparison of an experimental diet to its appropriate matched control diet is critical for a rigorous interpretation of results [refs. <sup><xref rid="R13" ref-type="bibr">13</xref>&#x02013;<xref rid="R16" ref-type="bibr">16</xref></sup> and present data].</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>Supinfo1</label><media xlink:href="NIHMS1971977-supplement-Supinfo1.tif" id="d66e781" position="anchor"/></supplementary-material><supplementary-material id="SD2" position="float" content-type="local-data"><label>Supinfo2</label><media xlink:href="NIHMS1971977-supplement-Supinfo2.tif" id="d66e784" position="anchor"/></supplementary-material><supplementary-material id="SD3" position="float" content-type="local-data"><label>Supinfo5</label><media xlink:href="NIHMS1971977-supplement-Supinfo5.pdf" id="d66e787" position="anchor"/></supplementary-material><supplementary-material id="SD4" position="float" content-type="local-data"><label>Supinfo3</label><media xlink:href="NIHMS1971977-supplement-Supinfo3.tif" id="d66e790" position="anchor"/></supplementary-material><supplementary-material id="SD5" position="float" content-type="local-data"><label>Supinfo6</label><media xlink:href="NIHMS1971977-supplement-Supinfo6.xlsx" id="d66e793" position="anchor"/></supplementary-material><supplementary-material id="SD6" position="float" content-type="local-data"><label>Supinfo7</label><media xlink:href="NIHMS1971977-supplement-Supinfo7.docx" id="d66e796" position="anchor"/></supplementary-material><supplementary-material id="SD7" position="float" content-type="local-data"><label>Supinfo4</label><media xlink:href="NIHMS1971977-supplement-Supinfo4.tif" id="d66e799" position="anchor"/></supplementary-material></sec></body><back><ack id="S25"><title>Acknowledgments</title><p id="P35">The authors&#x02019; laboratories are supported by NIH grants R01 DK123183-04 (J.J.C.) and P20 GM135002-04 (S.J.B.). We also thank the Core Facilities at PBRC, which are supported by NIH grants S10 OD023703 (AMBC) and P30 DK072476 (AMBC and Genomics). The authors report no conflicts of interest.</p></ack><fn-group><fn fn-type="COI-statement" id="FN3"><p id="P36">The authors have no disclosures.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Atkinson</surname><given-names>MA</given-names></name>, <name><surname>Eisenbarth</surname><given-names>GS</given-names></name>, <name><surname>Michels</surname><given-names>AW</given-names></name>. <article-title>Type 1 diabetes</article-title>. <source>Lancet</source>. <year>2014</year>;<volume>383</volume>(<issue>9911</issue>):<fpage>69</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">23890997</pub-id>
</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Martin</surname><given-names>TM</given-names></name>, <name><surname>Burke</surname><given-names>SJ</given-names></name>, <name><surname>Wasserfall</surname><given-names>CH</given-names></name>, <name><surname>Collier</surname><given-names>JJ</given-names></name>. <article-title>Islet beta-cells and intercellular adhesion molecule-1 (ICAM-1): Integrating immune responses that influence autoimmunity and graft rejection</article-title>. <source>Autoimmun Rev</source>. <year>2023</year>;<volume>22</volume>(<issue>10</issue>):<fpage>103414</fpage>.<pub-id pub-id-type="pmid">37619906</pub-id>
</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Collier</surname><given-names>JJ</given-names></name>, <name><surname>Sparer</surname><given-names>TE</given-names></name>, <name><surname>Karlstad</surname><given-names>MD</given-names></name>, <name><surname>Burke</surname><given-names>SJ</given-names></name>. <article-title>Pancreatic islet inflammation: an emerging role for chemokines</article-title>. <source>J Mol Endocrinol</source>. <year>2017</year>;<volume>59</volume>(<issue>1</issue>):<fpage>R33</fpage>&#x02013;<lpage>R46</lpage>.<pub-id pub-id-type="pmid">28420714</pub-id>
</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Pociot</surname><given-names>F</given-names></name>, <name><surname>Lernmark</surname><given-names>A</given-names></name>. <article-title>Genetic risk factors for type 1 diabetes</article-title>. <source>Lancet</source>. <year>2016</year>;<volume>387</volume>(<issue>10035</issue>):<fpage>2331</fpage>&#x02013;<lpage>2339</lpage>.<pub-id pub-id-type="pmid">27302272</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Suri</surname><given-names>A</given-names></name>, <name><surname>Walters</surname><given-names>JJ</given-names></name>, <name><surname>Gross</surname><given-names>ML</given-names></name>, <name><surname>Unanue</surname><given-names>ER</given-names></name>. <article-title>Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity</article-title>. <source>J Clin Invest</source>. <year>2005</year>;<volume>115</volume>(<issue>8</issue>):<fpage>2268</fpage>&#x02013;<lpage>2276</lpage>.<pub-id pub-id-type="pmid">16075062</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Filippi</surname><given-names>CM</given-names></name>, <name><surname>von Herrath</surname><given-names>MG</given-names></name>. <article-title>Viral trigger for type 1 diabetes: pros and cons</article-title>. <source>Diabetes</source>. <year>2008</year>;<volume>57</volume>(<issue>11</issue>):<fpage>2863</fpage>&#x02013;<lpage>2871</lpage>.<pub-id pub-id-type="pmid">18971433</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Miller</surname><given-names>KM</given-names></name>, <name><surname>Hart</surname><given-names>PH</given-names></name>, <name><surname>Lucas</surname><given-names>RM</given-names></name>, <name><surname>Davis</surname><given-names>EA</given-names></name>, <name><surname>de Klerk</surname><given-names>NH</given-names></name>. <article-title>Higher ultraviolet radiation during early life is associated with lower risk of childhood type 1 diabetes among boys</article-title>. <source>Sci Rep</source>. <year>2021</year>;<volume>11</volume>(<issue>1</issue>):<fpage>18597</fpage>.<pub-id pub-id-type="pmid">34545118</pub-id>
</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Miller</surname><given-names>KM</given-names></name>, <name><surname>Hart</surname><given-names>PH</given-names></name>, <name><surname>de Klerk</surname><given-names>NH</given-names></name>, <name><surname>Davis</surname><given-names>EA</given-names></name>, <name><surname>Lucas</surname><given-names>RM</given-names></name>. <article-title>Are low sun exposure and/or vitamin D risk factors for type 1 diabetes?</article-title>
<source>Photochem Photobiol Sci</source>. <year>2017</year>;<volume>16</volume>(<issue>3</issue>):<fpage>381</fpage>&#x02013;<lpage>398</lpage>.<pub-id pub-id-type="pmid">27922139</pub-id>
</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Bach</surname><given-names>JF</given-names></name>, <name><surname>Chatenoud</surname><given-names>L</given-names></name>. <article-title>The hygiene hypothesis: an explanation for the increased frequency of insulin-dependent diabetes</article-title>. <source>Cold Spring Harb Perspect Med</source>. <year>2012</year>;<volume>2</volume>(<issue>2</issue>):<fpage>a007799</fpage>.<pub-id pub-id-type="pmid">22355800</pub-id>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Virtanen</surname><given-names>SM</given-names></name>. <article-title>Dietary factors in the development of type 1 diabetes</article-title>. <source>Pediatr Diabetes</source>. <year>2016</year>;<volume>17 Suppl 22</volume>:<fpage>49</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">27411437</pub-id>
</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Bray</surname><given-names>GA</given-names></name>. <article-title>Obesity increases risk for diabetes</article-title>. <source>Int J Obes Relat Metab Disord</source>. <year>1992</year>;<volume>16 Suppl 4</volume>:<fpage>S13</fpage>&#x02013;<lpage>17</lpage>.</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Wilkin</surname><given-names>TJ</given-names></name>. <article-title>Is autoimmunity or insulin resistance the primary driver of type 1 diabetes?</article-title>
<source>Curr Diab Rep</source>. <year>2013</year>;<volume>13</volume>(<issue>5</issue>):<fpage>651</fpage>&#x02013;<lpage>656</lpage>.<pub-id pub-id-type="pmid">24005814</pub-id>
</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Dalby</surname><given-names>MJ</given-names></name>, <name><surname>Ross</surname><given-names>AW</given-names></name>, <name><surname>Walker</surname><given-names>AW</given-names></name>, <name><surname>Morgan</surname><given-names>PJ</given-names></name>. <article-title>Dietary Uncoupling of Gut Microbiota and Energy Harvesting from Obesity and Glucose Tolerance in Mice</article-title>. <source>Cell Rep</source>. <year>2017</year>;<volume>21</volume>(<issue>6</issue>):<fpage>1521</fpage>&#x02013;<lpage>1533</lpage>.<pub-id pub-id-type="pmid">29117558</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Warden</surname><given-names>CH</given-names></name>, <name><surname>Fisler</surname><given-names>JS</given-names></name>. <article-title>Comparisons of diets used in animal models of high-fat feeding</article-title>. <source>Cell Metab</source>. <year>2008</year>;<volume>7</volume>(<issue>4</issue>):<fpage>277</fpage>.<pub-id pub-id-type="pmid">18396128</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Pellizzon</surname><given-names>MA</given-names></name>, <name><surname>Ricci</surname><given-names>MR</given-names></name>. <article-title>The common use of improper control diets in diet-induced metabolic disease research confounds data interpretation: the fiber factor</article-title>. <source>Nutr Metab (Lond)</source>. <year>2018</year>;<volume>15</volume>:<fpage>3</fpage>.<pub-id pub-id-type="pmid">29371873</pub-id>
</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Klatt</surname><given-names>KC</given-names></name>, <name><surname>Bass</surname><given-names>K</given-names></name>, <name><surname>Speakman</surname><given-names>JR</given-names></name>, <name><surname>Hall</surname><given-names>KD</given-names></name>. <article-title>Chowing down: diet considerations in rodent models of metabolic disease</article-title>. <source>Life Metab</source>. <year>2023</year>;<volume>2</volume>(<issue>3</issue>).</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Atkinson</surname><given-names>MA</given-names></name>, <name><surname>Chervonsky</surname><given-names>A</given-names></name>. <article-title>Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease</article-title>. <source>Diabetologia</source>. <year>2012</year>;<volume>55</volume>(<issue>11</issue>):<fpage>2868</fpage>&#x02013;<lpage>2877</lpage>.<pub-id pub-id-type="pmid">22875196</pub-id>
</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Alam</surname><given-names>C</given-names></name>, <name><surname>Bittoun</surname><given-names>E</given-names></name>, <name><surname>Bhagwat</surname><given-names>D</given-names></name>, <etal/>
<article-title>Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice</article-title>. <source>Diabetologia</source>. <year>2011</year>;<volume>54</volume>(<issue>6</issue>):<fpage>1398</fpage>&#x02013;<lpage>1406</lpage>.<pub-id pub-id-type="pmid">21380595</pub-id>
</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>King</surname><given-names>C</given-names></name>, <name><surname>Sarvetnick</surname><given-names>N</given-names></name>. <article-title>The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions</article-title>. <source>PLoS One</source>. <year>2011</year>;<volume>6</volume>(<issue>2</issue>):<fpage>e17049</fpage>.<pub-id pub-id-type="pmid">21364875</pub-id>
</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Wen</surname><given-names>L</given-names></name>, <name><surname>Ley</surname><given-names>RE</given-names></name>, <name><surname>Volchkov</surname><given-names>PY</given-names></name>, <etal/>
<article-title>Innate immunity and intestinal microbiota in the development of Type 1 diabetes</article-title>. <source>Nature</source>. <year>2008</year>;<volume>455</volume>(<issue>7216</issue>):<fpage>1109</fpage>&#x02013;<lpage>1113</lpage>.<pub-id pub-id-type="pmid">18806780</pub-id>
</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Schloss</surname><given-names>PD</given-names></name>, <name><surname>Westcott</surname><given-names>SL</given-names></name>, <name><surname>Ryabin</surname><given-names>T</given-names></name>, <etal/>
<article-title>Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities</article-title>. <source>Appl Environ Microbiol</source>. <year>2009</year>;<volume>75</volume>(<issue>23</issue>):<fpage>7537</fpage>&#x02013;<lpage>7541</lpage>.<pub-id pub-id-type="pmid">19801464</pub-id>
</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Quast</surname><given-names>C</given-names></name>, <name><surname>Pruesse</surname><given-names>E</given-names></name>, <name><surname>Yilmaz</surname><given-names>P</given-names></name>, <etal/>
<article-title>The SILVA ribosomal RNA gene database project: improved data processing and web-based tools</article-title>. <source>Nucleic Acids Res</source>. <year>2013</year>;<volume>41</volume>(<issue>Database issue</issue>):<fpage>D590</fpage>&#x02013;<lpage>596</lpage>.<pub-id pub-id-type="pmid">23193283</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>Y</given-names></name>, <name><surname>Zhou</surname><given-names>G</given-names></name>, <name><surname>Ewald</surname><given-names>J</given-names></name>, <name><surname>Pang</surname><given-names>Z</given-names></name>, <name><surname>Shiri</surname><given-names>T</given-names></name>, <name><surname>Xia</surname><given-names>J</given-names></name>. <article-title>MicrobiomeAnalyst 2.0: comprehensive statistical, functional and integrative analysis of microbiome data</article-title>. <source>Nucleic Acids Res</source>. <year>2023</year>;<volume>51</volume>(<issue>W1</issue>):<fpage>W310</fpage>&#x02013;<lpage>W318</lpage>.<pub-id pub-id-type="pmid">37166960</pub-id>
</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Burke</surname><given-names>SJ</given-names></name>, <name><surname>Batdorf</surname><given-names>HM</given-names></name>, <name><surname>Eder</surname><given-names>AE</given-names></name>, <etal/>
<article-title>Oral Corticosterone Administration Reduces Insulitis but Promotes Insulin Resistance and Hyperglycemia in Male Nonobese Diabetic Mice</article-title>. <source>Am J Pathol</source>. <year>2017</year>;<volume>187</volume>(<issue>3</issue>):<fpage>614</fpage>&#x02013;<lpage>626</lpage>.<pub-id pub-id-type="pmid">28061324</pub-id>
</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Burke</surname><given-names>SJ</given-names></name>, <name><surname>Karlstad</surname><given-names>MD</given-names></name>, <name><surname>Eder</surname><given-names>AE</given-names></name>, <etal/>
<article-title>Pancreatic beta-Cell production of CXCR3 ligands precedes diabetes onset</article-title>. <source>Biofactors</source>. <year>2016</year>;<volume>42</volume>(<issue>6</issue>):<fpage>703</fpage>&#x02013;<lpage>715</lpage>.<pub-id pub-id-type="pmid">27325565</pub-id>
</mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Makgoba</surname><given-names>MW</given-names></name>, <name><surname>Sanders</surname><given-names>ME</given-names></name>, <name><surname>Ginther Luce</surname><given-names>GE</given-names></name>, <etal/>
<article-title>ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells</article-title>. <source>Nature</source>. <year>1988</year>;<volume>331</volume>(<issue>6151</issue>):<fpage>86</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="pmid">3277059</pub-id>
</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Duarte</surname><given-names>JA</given-names></name>, <name><surname>Carvalho</surname><given-names>F</given-names></name>, <name><surname>Pearson</surname><given-names>M</given-names></name>, <etal/>
<article-title>A high-fat diet suppresses de novo lipogenesis and desaturation but not elongation and triglyceride synthesis in mice</article-title>. <source>J Lipid Res</source>. <year>2014</year>;<volume>55</volume>(<issue>12</issue>):<fpage>2541</fpage>&#x02013;<lpage>2553</lpage>.<pub-id pub-id-type="pmid">25271296</pub-id>
</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Singh</surname><given-names>SB</given-names></name>, <name><surname>Carroll-Portillo</surname><given-names>A</given-names></name>, <name><surname>Lin</surname><given-names>HC</given-names></name>. <article-title>Desulfovibrio in the Gut: The Enemy within?</article-title>
<source>Microorganisms</source>. <year>2023</year>;<volume>11</volume>(<issue>7</issue>).</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Lawrence</surname><given-names>JM</given-names></name>, <name><surname>Divers</surname><given-names>J</given-names></name>, <name><surname>Isom</surname><given-names>S</given-names></name>, <etal/>
<article-title>Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001&#x02013;2017</article-title>. <source>JAMA</source>. <year>2021</year>;<volume>326</volume>(<issue>8</issue>):<fpage>717</fpage>&#x02013;<lpage>727</lpage>.<pub-id pub-id-type="pmid">34427600</pub-id>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>YG</given-names></name>, <name><surname>Mathews</surname><given-names>CE</given-names></name>, <name><surname>Driver</surname><given-names>JP</given-names></name>. <article-title>The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future</article-title>. <source>Front Endocrinol (Lausanne)</source>. <year>2018</year>;<volume>9</volume>:<fpage>51</fpage>.<pub-id pub-id-type="pmid">29527189</pub-id>
</mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Clark</surname><given-names>AL</given-names></name>, <name><surname>Yan</surname><given-names>Z</given-names></name>, <name><surname>Chen</surname><given-names>SX</given-names></name>, <etal/>
<article-title>High-fat diet prevents the development of autoimmune diabetes in NOD mice</article-title>. <source>Diabetes Obes Metab</source>. <year>2021</year>;<volume>23</volume>(<issue>11</issue>):<fpage>2455</fpage>&#x02013;<lpage>2465</lpage>.<pub-id pub-id-type="pmid">34212475</pub-id>
</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Kleinert</surname><given-names>M</given-names></name>, <name><surname>Clemmensen</surname><given-names>C</given-names></name>, <name><surname>Hofmann</surname><given-names>SM</given-names></name>, <etal/>
<article-title>Animal models of obesity and diabetes mellitus</article-title>. <source>Nat Rev Endocrinol</source>. <year>2018</year>;<volume>14</volume>(<issue>3</issue>):<fpage>140</fpage>&#x02013;<lpage>162</lpage>.<pub-id pub-id-type="pmid">29348476</pub-id>
</mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Sosenko</surname><given-names>JM</given-names></name>, <name><surname>Palmer</surname><given-names>JP</given-names></name>, <name><surname>Greenbaum</surname><given-names>CJ</given-names></name>, <etal/>
<article-title>Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1</article-title>. <source>Diabetes Care</source>. <year>2006</year>;<volume>29</volume>(<issue>3</issue>):<fpage>643</fpage>&#x02013;<lpage>649</lpage>.<pub-id pub-id-type="pmid">16505520</pub-id>
</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Sosenko</surname><given-names>JM</given-names></name>, <name><surname>Skyler</surname><given-names>JS</given-names></name>, <name><surname>Herold</surname><given-names>KC</given-names></name>, <name><surname>Palmer</surname><given-names>JP</given-names></name>, <article-title>Type 1 Diabetes T, Diabetes Prevention Trial-Type 1 Study G. The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1</article-title>. <source>Diabetes</source>. <year>2012</year>;<volume>61</volume>(<issue>6</issue>):<fpage>1331</fpage>&#x02013;<lpage>1337</lpage>.<pub-id pub-id-type="pmid">22618768</pub-id>
</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Roden</surname><given-names>M</given-names></name>, <name><surname>Stingl</surname><given-names>H</given-names></name>, <name><surname>Chandramouli</surname><given-names>V</given-names></name>, <etal/>
<article-title>Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans</article-title>. <source>Diabetes</source>. <year>2000</year>;<volume>49</volume>(<issue>5</issue>):<fpage>701</fpage>&#x02013;<lpage>707</lpage>.<pub-id pub-id-type="pmid">10905476</pub-id>
</mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Valera</surname><given-names>A</given-names></name>, <name><surname>Pujol</surname><given-names>A</given-names></name>, <name><surname>Pelegrin</surname><given-names>M</given-names></name>, <name><surname>Bosch</surname><given-names>F</given-names></name>. <article-title>Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1994</year>;<volume>91</volume>(<issue>19</issue>):<fpage>9151</fpage>&#x02013;<lpage>9154</lpage>.<pub-id pub-id-type="pmid">8090784</pub-id>
</mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>Collier</surname><given-names>JJ</given-names></name>, <name><surname>Scott</surname><given-names>DK</given-names></name>. <article-title>Sweet changes: glucose homeostasis can be altered by manipulating genes controlling hepatic glucose metabolism</article-title>. <source>Mol Endocrinol</source>. <year>2004</year>;<volume>18</volume>(<issue>5</issue>):<fpage>1051</fpage>&#x02013;<lpage>1063</lpage>.<pub-id pub-id-type="pmid">14694084</pub-id>
</mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>Antras-Ferry</surname><given-names>J</given-names></name>, <name><surname>Le Bigot</surname><given-names>G</given-names></name>, <name><surname>Robin</surname><given-names>P</given-names></name>, <name><surname>Robin</surname><given-names>D</given-names></name>, <name><surname>Forest</surname><given-names>C</given-names></name>. <article-title>Stimulation of phosphoenolpyruvate carboxykinase gene expression by fatty acids</article-title>. <source>Biochem Biophys Res Commun</source>. <year>1994</year>;<volume>203</volume>(<issue>1</issue>):<fpage>385</fpage>&#x02013;<lpage>391</lpage>.<pub-id pub-id-type="pmid">8074682</pub-id>
</mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><name><surname>Wrightington</surname><given-names>M</given-names></name>
<article-title>The Effect of Glucose and Sucrose on the Respiratory Quotient and Muscular Efficiency of Exercise</article-title>. <source>The Journal of Nutrition</source>. <year>1942</year>;<volume>24</volume>(<issue>4</issue>):<fpage>307</fpage>&#x02013;<lpage>315</lpage>.</mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><name><surname>Benade</surname><given-names>AJ</given-names></name>, <name><surname>Wyndham</surname><given-names>CH</given-names></name>, <name><surname>Jansen</surname><given-names>CR</given-names></name>, <name><surname>Rogers</surname><given-names>GG</given-names></name>, <name><surname>de Bruin</surname><given-names>EJ</given-names></name>. <article-title>Plasma insulin and carbohydrate metabolism after sucrose ingestion during rest and prolonged aerobic exercise</article-title>. <source>Pflugers Arch</source>. <year>1973</year>;<volume>342</volume>(<issue>3</issue>):<fpage>207</fpage>&#x02013;<lpage>218</lpage>.<pub-id pub-id-type="pmid">4795809</pub-id>
</mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><name><surname>Burke</surname><given-names>SJ</given-names></name>, <name><surname>Batdorf</surname><given-names>HM</given-names></name>, <name><surname>Martin</surname><given-names>TM</given-names></name>, <etal/>
<article-title>Liquid Sucrose Consumption Promotes Obesity and Impairs Glucose Tolerance Without Altering Circulating Insulin Levels</article-title>. <source>Obesity (Silver Spring)</source>
<year>2018</year>;<volume>26</volume>(<issue>7</issue>):<fpage>1188</fpage>&#x02013;<lpage>1196</lpage>.<pub-id pub-id-type="pmid">29901267</pub-id>
</mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal"><name><surname>Insel</surname><given-names>RA</given-names></name>, <name><surname>Dunne</surname><given-names>JL</given-names></name>, <name><surname>Atkinson</surname><given-names>MA</given-names></name>, <etal/>
<article-title>Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association</article-title>. <source>Diabetes Care</source>. <year>2015</year>;<volume>38</volume>(<issue>10</issue>):<fpage>1964</fpage>&#x02013;<lpage>1974</lpage>.<pub-id pub-id-type="pmid">26404926</pub-id>
</mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal"><name><surname>Cella</surname><given-names>M</given-names></name>, <name><surname>Engering</surname><given-names>A</given-names></name>, <name><surname>Pinet</surname><given-names>V</given-names></name>, <name><surname>Pieters</surname><given-names>J</given-names></name>, <name><surname>Lanzavecchia</surname><given-names>A</given-names></name>. <article-title>Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells</article-title>. <source>Nature</source>. <year>1997</year>;<volume>388</volume>(<issue>6644</issue>):<fpage>782</fpage>&#x02013;<lpage>787</lpage>.<pub-id pub-id-type="pmid">9285591</pub-id>
</mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><name><surname>Facchini</surname><given-names>FS</given-names></name>, <name><surname>Hua</surname><given-names>N</given-names></name>, <name><surname>Abbasi</surname><given-names>F</given-names></name>, <name><surname>Reaven</surname><given-names>GM</given-names></name>. <article-title>Insulin resistance as a predictor of age-related diseases</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2001</year>;<volume>86</volume>(<issue>8</issue>):<fpage>3574</fpage>&#x02013;<lpage>3578</lpage>.<pub-id pub-id-type="pmid">11502781</pub-id>
</mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal"><name><surname>Rollins</surname><given-names>CPE</given-names></name>, <name><surname>Gallino</surname><given-names>D</given-names></name>, <name><surname>Kong</surname><given-names>V</given-names></name>, <etal/>
<article-title>Contributions of a high-fat diet to Alzheimer&#x02019;s disease-related decline: A longitudinal behavioural and structural neuroimaging study in mouse models</article-title>. <source>Neuroimage Clin</source>. <year>2019</year>;<volume>21</volume>:<fpage>101606</fpage>.<pub-id pub-id-type="pmid">30503215</pub-id>
</mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal"><name><surname>Gianfrancesco</surname><given-names>MA</given-names></name>, <name><surname>Barcellos</surname><given-names>LF</given-names></name>. <article-title>Obesity and Multiple Sclerosis Susceptibility: A Review</article-title>. <source>J Neurol Neuromedicine</source>. <year>2016</year>;<volume>1</volume>(<issue>7</issue>):<fpage>1</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Figure 1.</label><caption><title>Refined high-fat diet promotes glucose intolerance and increased incidence of hyperglycemia in female NOD mice.</title><p id="P37"><bold>A</bold>. Glucose tolerance tests (GTTs) conducted in 14 week old (wo) female NOD mice. <bold>B</bold>. Glucose tolerance tests conducted in 14&#x02013;16 wo female NOD mice. <bold>C</bold>. The incidence of diabetes was monitored twice weekly starting at 8 weeks of age (n = 25&#x02013;28 per dietary group). Mice were considered diabetic after two consecutive values &#x02265; 250mg/dL. Dashed line indicates 50% threshold. GTT data are shown as means &#x000b1; SEM while diabetes incidence was plotted using Kaplan-Meier curves. #, p &#x0003c; 0.1; *, p &#x0003c; 0.05; n.s., not significant.</p></caption><graphic xlink:href="nihms-1971977-f0001" position="float"/></fig><fig position="float" id="F2"><label>Figure 2.</label><caption><title>Respiratory quotient is impacted by diet in female NOD mice.</title><p id="P38">Respiratory quotient in mice fed either unrefined (<bold>A &#x02013; C</bold>) or refined diets (<bold>D &#x02013; F</bold>). <bold>A, D</bold>. RQ across the light (white sections) and dark (grey sections) cycle over a seven day period. <bold>B, E</bold>. Cumulative mean RQ over seven days. <bold>C, F</bold>. Cumulative mean RQ parsed into lights on and lights off over seven days in metabolic cages. Bar graphs represent data as means &#x000b1; SEM. ****, p &#x0003c; 0.0001. n = 8 per group.</p></caption><graphic xlink:href="nihms-1971977-f0002" position="float"/></fig><fig position="float" id="F3"><label>Figure 3.</label><caption><title>Circulating insulin is influenced by dietary fat content and reflective of diabetes status.</title><p id="P39">Serum insulin values from mice fed unrefined (<bold>A;</bold> n = 8&#x02013;19) and refined (<bold>D</bold>; n = 9&#x02013;19) diets per group separated by glucose threshold of &#x0003c; 250 mg/dL (normoglycemia; NG) and &#x02265; 250 mg/dL (hyperglycemia; HG). Scoring of immune cell infiltration (insulitis) using a 0&#x02013;3 scale described in the <xref rid="S6" ref-type="sec">methods</xref> separated by glucose threshold of &#x0003c; 250 mg/dL (NG) and &#x02265; 250 mg/dL (HG) from mice fed unrefined diets (<bold>B;</bold> n = 16) and refined (<bold>E</bold>; n = 24). <bold>D</bold>. Five color IF imaging showing single channel and merge of FFPE pancreatic tissue stained for individual immune cells (i.e. Foxp3, CD3, and Iba1) and insulin positive cells from mice fed unrefined (<bold>C;</bold> n = 6) and refined diets (<bold>F</bold>; n = 6). Islets of similar size were compared. Scale bar = 100 &#x003bc;m.</p></caption><graphic xlink:href="nihms-1971977-f0003" position="float"/></fig><fig position="float" id="F4"><label>Figure 4.</label><caption><title>Liver gene expression is altered by refined high-fat feeding.</title><p id="P40">Expression of <italic toggle="yes">Acaca</italic> (<bold>A</bold>), <italic toggle="yes">Fasn</italic> (<bold>B</bold>), <italic toggle="yes">Dgat1</italic> (<bold>C</bold>), <italic toggle="yes">Dgat2</italic>, (<bold>D</bold>) <italic toggle="yes">Slc2a2</italic> (<bold>E</bold>), and <italic toggle="yes">Pck1</italic> (<bold>F</bold>) measured by RT-PCR using RNA isolated from liver (n = 8 per group). Data are presented as mean &#x000b1; SEM, where * denotes p &#x0003c; 0.05, &#x0200b;** p &#x0003c; 0 .01 and *** p &#x0003c; 0.001.</p></caption><graphic xlink:href="nihms-1971977-f0004" position="float"/></fig><fig position="float" id="F5"><label>Figure 5.</label><caption><title>Alpha and beta diversity show clustering largely by dietary type (unrefined versus refined).</title><p id="P41"><bold>A</bold>. The observed compositional diversity is greater in the unrefined (chow) fed groups compared to the refined low- and high-fat fed mice. <bold>B</bold>. The differences in microbiota composition across the four distinct dietary groups. n = 8 per dietary group.</p></caption><graphic xlink:href="nihms-1971977-f0005" position="float"/></fig></floats-group></article>